Bioventus (BVS) FCF Margin (2020 - 2026)
Bioventus (BVS) reported FCF Margin of 6.36% for Q1 2026, up 2208.0% on a YoY basis from 0.28% in Q1 2025, and down 73.54% quarter-over-quarter from 24.03% in Q4 2025.
Bioventus (BVS) FCF Margin (2020 - 2026) Analysis & Trends
Bioventus has reported FCF Margin for 7 years, with the latest figure at 6.36% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 2208.0% year-over-year to 6.36%; the trailing twelve-month figure through Mar 2026 stood at 17.75% (up 1342.0% YoY), and the FY2025 full-year result was 13.1%, up 651.0% from the prior year.
- FCF Margin for Q1 2026 stood at 6.36%, down from 24.03% in the prior quarter.
- The five-year high for FCF Margin was 24.03% in Q4 2025, with the low at 20.44% in Q2 2022.
- Historically, FCF Margin has averaged 4.36% across 5 years, with a median of 6.36% in 2026.
- Annual changes were most pronounced in 2022 — FCF Margin sank 1397 bps — and 2026, when it soared 2208 bps.
- Bioventus' FCF Margin stood at 9.28% in 2022, then sank by 66 bps to 3.19% in 2023, then soared by 276 bps to 11.99% in 2024, then jumped by 100 bps to 24.03% in 2025, then tumbled by 74 bps to 6.36% in 2026.
- The last three FCF Margin figures came in at 6.36% (Q1 2026), 24.03% (Q4 2025), and 22.64% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -1.28% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 3.98% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 37.67% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 15.44% |
| 10 | Bioventus | 571.68 Mn | 581.20 Mn | 90.77 Mn | 6.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 6.36% |
| Dec 31, 2025 | 24.03% |
| Sep 27, 2025 | 22.64% |
| Jun 28, 2025 | 16.64% |
| Mar 29, 2025 | -15.72% |
| Dec 31, 2024 | 11.99% |
| Sep 28, 2024 | 7.49% |
| Jun 29, 2024 | 10.08% |
| Mar 30, 2024 | -4.86% |
| Dec 31, 2023 | 3.19% |
| Sep 30, 2023 | -2.06% |
| Jul 1, 2023 | 6.86% |
| Apr 1, 2023 | -0.90% |
| Dec 31, 2022 | 9.28% |
| Oct 1, 2022 | -1.16% |
| Jul 2, 2022 | 0.65% |
| Apr 2, 2022 | -20.44% |
| Dec 31, 2021 | 0.16% |
| Oct 2, 2021 | 11.59% |
| Jul 3, 2021 | 14.62% |